Atlas Trials

Evaluation of a Plasma Protein Profile as a Predictive Biomarker for Metastatic Relapse in Triple Negative Breast Cancer Patients

Clinical trial NCT04438681 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT04438681
Sponsor
Centre Jean Perrin
Status
ACTIVE_NOT_RECRUITING
Study type
OBSERVATIONAL
Triple Negative Breast Cancer
Start date
2020-11-27
Primary completion
2026-11-09
Enrollment
90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.